Background One of the most malignant tumors in men is prostate cancer that is still incurable
due to its heterogenous and progressive natures. Genetic and epigenetic changes play …

The acquisition of cancer cell resistance to conventional chemotherapeutics is considered
the major driver of treatment failure and disease recurrence in most solid and hematological …

Epithelial-to-mesenchymal transition (EMT) is a process that involves the transformation of
polarized epithelial cells to attain a mesenchymal phenotype that presents an elevated …

In the entire world, prostate cancer (PCa) is one of the most common and deadly cancers.
Treatment failure is still common among patients, despite PCa diagnosis and treatment …

RNA molecules lacking capacity in protein translation, are known as non-coding RNAs
(ncRNAs). Growth, differentiation and migration are influenced by ncRNAs in cells. The …

Ewing sarcoma (ES) is a highly malignant primary bone tumor with poor prognosis. Studies
have shown that abnormal expression of lncRNA influences the prognosis of tumor patients …

Prostate cancer (PCa) progression relies on androgen receptor (AR) function, making AR a
top candidate for PCa therapy. However, development of drug resistance is common, which …

Long non-coding RNAs (lncRNAs) are regulatory transcripts with essential roles in the
pathogenesis of almost all types of cancers, including prostate cancer. They can act as …

Long non-coding RNA (lncRNA) plays an important role in the regulation of gene expression
in normal and cancer cells. We previously discovered a novel tumor-suppressive lncRNA …

Despite advancements, prostate cancers (PCa) are a significant global health due to
delayed diagnosis and therapeutic resistance. This review delves into the complex …